Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8RM8

Cryo-EM structure of human islet amyloid polypeptide (hIAPP) mutant S28P, polymorph 1

Summary for 8RM8
Entry DOI10.2210/pdb8rm8/pdb
Related8QJ1 8QVP 8QVQ 8QVR 8R1S
EMDB information19353
DescriptorIslet amyloid polypeptide (1 entity in total)
Functional Keywordsamyloid, protein fibril
Biological sourceHomo sapiens (human)
Total number of polymer chains10
Total formula weight39173.49
Authors
Ooi, S.A.,Valli, D.,Maj, M. (deposition date: 2024-01-05, release date: 2025-07-30, Last modification date: 2026-02-11)
Primary citationOoi, S.A.,Valli, D.,Kuska, M.I.,Mari, H.,Chaudhary, H.,Wahlgren, W.Y.,Westenhoff, S.,Tietze, A.A.,Novials, A.,Servitja, J.M.,Maj, M.
Cryo-EM exposes diverse polymorphism in IAPP mutants to guide the rational design of peptide-based therapeutics.
J.Mol.Biol., 437:169405-169405, 2025
Cited by
PubMed Abstract: In the pursuit of potential therapeutic agents for type 2 diabetes, non-amyloidogenic forms of the human Islet Amyloid Polypeptide (hIAPP) containing site-specific mutations are of significant interest. In the present study, we dissect the three proline mutations present in the core region of the non-amyloidogenic rat IAPP into single-point mutations at A25P, S28P, and S29P sites. We apply high-resolution cryo-electron microscopy and solve the structures of 6 polymorphs formed by these mutants, revealing the peptide's self-assembly patterns and identifying critical interactions that reinforce these structures in the presence of the β-sheet breaker. A unique trimeric aggregate with C3 symmetry was identified in the A25P mutant, which we resolved with a 3.05 Å resolution, while asymmetric trimeric assemblies were observed in the other mutants. Guided by the high-resolution structural models of A25P and S28P fibrils obtained in our study, we successfully designed novel non-amyloidogenic mutants of IAPP with potential therapeutic value. Our findings demonstrate the immense potential of structure-based approaches in developing effective therapeutics against amyloid diseases.
PubMed: 40850490
DOI: 10.1016/j.jmb.2025.169405
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3 Å)
Structure validation

249697

PDB entries from 2026-02-25

PDB statisticsPDBj update infoContact PDBjnumon